Dec 13, 2018

Aethlon Announces Appointment of Timothy Rodell as Interim Chief Executive Officer

Nov 27, 2018

Aethlon Medical's Cancer Therapy Receives "Breakthrough Device" Designation from the U.S. Food and Drug Administration

Nov 6, 2018

Aethlon Medical Announces Second Quarter Fiscal Year 2019 Results

Nov 1, 2018

Aethlon Medical To Release Quarterly Financial Results and Host Conference Call on November 6, 2018

Oct 29, 2018

Aethlon Medical to Present at the NYC Oncology Conference

Oct 16, 2018

Aethlon Medical to Present at the 2018 BIO Investor Forum

Sep 18, 2018

Aethlon Medical Receives National Cancer Institute Award

Aug 8, 2018

Aethlon Medical Announces First Quarter Fiscal Year 2019 Results

Aug 2, 2018

Aethlon Medical To Release Financial Results for the First Quarter Fiscal Year 2019 and Host Conference Call on August 8, 2018

Jul 23, 2018

Aethlon Medical Announces Issuance of Hemopurifier® Patent To Treat Life-Threatening Viruses